Aquatet 100%w/w Oral Powder

Land: Írland

Tungumál: enska

Heimild: HPRA (Health Products Regulatory Authority)

Virkt innihaldsefni:

Oxytetracycline hydrochloride

Fáanlegur frá:

Pharmaq Ltd.

ATC númer:

QJ01AA06

INN (Alþjóðlegt nafn):

Oxytetracycline hydrochloride

Skammtar:

100 percent weight/weight

Lyfjaform:

Oral powder

Gerð lyfseðils:

POM: Prescription Only Medicine as defined in relevant national legislation

Meðferðarhópur:

Atlantic salmon

Lækningarsvæði:

oxytetracycline

Ábendingar:

Antibacterial

Leyfisstaða:

Authorised

Leyfisdagur:

1996-03-22

Vara einkenni

SUMMARY OF PRODUCT CHARACTERISTICS
1 NAME OF THE VETERINARY MEDICINAL PRODUCT
Aquatet 100%w/w Oral Powder
2 QUALITATIVE AND QUANTITATIVE COMPOSITION
ACTIVE SUBSTANCE:
Oxytetracycline hydrochloride 100 %w/w
3 PHARMACEUTICAL FORM
Oral powder.
4 CLINICAL PARTICULARS
4.1 TARGET SPECIES
Salmon.
4.2 INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES
Treatment and control of furunculosis due to_ Aeromonas salmonicida_
in Atlantic salmon.
4.3 CONTRAINDICATIONS
Fish must not be slaughtered for human consumption during treatment.
4.4 SPECIAL WARNINGS FOR EACH TARGET SPECIES
Medicated feed should be used for the treatment period only.
4.5 SPECIAL PRECAUTIONS FOR USE
SPECIAL PRECAUTIONS FOR USE IN ANIMALS:
None.
SPECIAL PRECAUTIONS TO BE TAKEN BY THE PERSON ADMINISTERING THE
VETERINARY MEDICINAL PRODUCT TO ANIMALS:
Avoid inhaling dust, wear rubber gloves and a dust mask which at least
complies with European Standard EN149, FFP2 to
avoid inhalation of any
dust particles.
4.6 ADVERSE REACTIONS (FREQUENCY AND SERIOUSNESS)
No adverse effects are observed when the product is administered at
normal dose.
H
E
A
L
T
H
P
R
O
D
U
C
T
S
R
E
G
U
L
A
T
O
R
Y
A
U
T
H
O
R
I
T
Y
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
_D_
_a_
_t_
_e_
_ _
_P_
_r_
_i_
_n_
_t_
_e_
_d_
_ _
_1_
_6_
_/_
_0_
_7_
_/_
_2_
_0_
_1_
_4_
_C_
_R_
_N_
_ _
_7_
_0_
_1_
_5_
_2_
_0_
_1_
_p_
_a_
_g_
_e_
_ _
_n_
_u_
_m_
_b_
_e_
_r_
_:_
_ _
_1_
4.7 USE DURING PREGNANCY, LACTATION OR LAY
This product may be used on broodstock.
4.8 INTERACTION WITH OTHER MEDICINAL PRODUCTS AND OTHER FORMS OF
INTERACTION
Do not administer together with Growth Promoters or ot